The Food and Drug Administration this month put out the call for public comment about the long list of side effects tagged to the tail end of prescription drug advertisements on television.
Forbes reports FDA Commissioner Scott Gottlieb is shifting his focus to that lengthy list of risks, saying he wants to decrease it altogether. Gottlieb says a shorter list could potentially better consumers’ risk assessment.
“The FDA’s own research on broadcast TV drug advertisements suggests that a more targeted method for delivering risk information may lead to better retention of those risks,” Gottlieb said. “Our goal is to make sure consumers who view broadcast ads walk away properly informed of the key potential trade offs of using a prescription medicine.”